AU1767283A - Lysergic acid derivatives - Google Patents

Lysergic acid derivatives

Info

Publication number
AU1767283A
AU1767283A AU17672/83A AU1767283A AU1767283A AU 1767283 A AU1767283 A AU 1767283A AU 17672/83 A AU17672/83 A AU 17672/83A AU 1767283 A AU1767283 A AU 1767283A AU 1767283 A AU1767283 A AU 1767283A
Authority
AU
Australia
Prior art keywords
acid derivatives
lysergic acid
lysergic
derivatives
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU17672/83A
Other versions
AU563736B2 (en
Inventor
Peter Gull
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of AU1767283A publication Critical patent/AU1767283A/en
Application granted granted Critical
Publication of AU563736B2 publication Critical patent/AU563736B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
AU17672/83A 1982-08-09 1983-08-08 Lysergic acid derivatives Expired - Fee Related AU563736B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH4772/82A CH649998A5 (en) 1982-08-09 1982-08-09 ERGOL DERIVATIVES, A METHOD FOR THEIR PRODUCTION AND HEALING AGENTS, CONTAINING THESE ERGOL DERIVATIVES AS AN ACTIVE SUBSTANCE.
CH4772/82 1982-08-09

Publications (2)

Publication Number Publication Date
AU1767283A true AU1767283A (en) 1984-02-16
AU563736B2 AU563736B2 (en) 1987-07-23

Family

ID=4282273

Family Applications (1)

Application Number Title Priority Date Filing Date
AU17672/83A Expired - Fee Related AU563736B2 (en) 1982-08-09 1983-08-08 Lysergic acid derivatives

Country Status (23)

Country Link
JP (1) JPS5948480A (en)
AT (1) AT383125B (en)
AU (1) AU563736B2 (en)
BE (1) BE897473A (en)
CA (1) CA1215972A (en)
CH (1) CH649998A5 (en)
DE (1) DE3327705A1 (en)
DK (1) DK361983A (en)
ES (1) ES524815A0 (en)
FI (1) FI73679C (en)
FR (1) FR2531433B1 (en)
GB (1) GB2125041B (en)
GR (1) GR78923B (en)
HU (1) HU187600B (en)
IL (1) IL69450A (en)
IT (1) IT1168961B (en)
MY (1) MY8700166A (en)
NL (1) NL8302776A (en)
NZ (1) NZ205181A (en)
PH (1) PH20385A (en)
PT (1) PT77168B (en)
SE (1) SE8304315L (en)
ZA (1) ZA835850B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675322A (en) * 1984-12-10 1987-06-23 Eli Lilly And Company 1-Substituted-6-n-propyl-8β-methylthio-methylergolines
HU193782B (en) * 1985-06-21 1987-11-30 Richter Gedeon Vegyeszet Process for producing 2-halogeno-nicergoline derivatives and acid additional salts thereof
FR2589734B1 (en) * 1985-11-13 1988-09-02 Roussel Uclaf USE OF ERGOLIN DERIVATIVES FOR OBTAINING A GERIATRIC MEDICINE
US4798834A (en) * 1987-08-31 1989-01-17 Eli Lilly And Company Optionally substituted (3β-9,10-didehydro-2,3-dihydro ergoline as serotonergic function enhancement
DE3913756A1 (en) * 1989-04-21 1990-10-25 Schering Ag 8 (BETA) SUBSTITUTED ERGOLINE, METHOD FOR THE PRODUCTION AND USE THEREOF
DE10212564B4 (en) * 2002-03-12 2007-04-19 Neurobiotec Gmbh 1-Allyl ergot alkaloid derivatives and their use for the prophylaxis and treatment of migraine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE41533B1 (en) * 1974-03-14 1980-01-30 Sandoz Ltd Thiomethyl ergolene derivatives
US3901894A (en) * 1974-06-06 1975-08-26 Lilly Co Eli 8-thiomethylergolines
US3959288A (en) * 1974-12-13 1976-05-25 Eli Lilly And Company 8-Oxymethylergolines and process therefor
US4166182A (en) * 1978-02-08 1979-08-28 Eli Lilly And Company 6-n-propyl-8-methoxymethyl or methylmercaptomethylergolines and related compounds
US4382940A (en) * 1979-12-06 1983-05-10 Farmitalia Carlo Erba S.P.A. Ercoline derivatives and therapeutic compositions having CNS affecting activity

Also Published As

Publication number Publication date
ZA835850B (en) 1985-03-27
CA1215972A (en) 1986-12-30
JPS5948480A (en) 1984-03-19
AT383125B (en) 1987-05-25
FI832789A0 (en) 1983-08-02
GB2125041A (en) 1984-02-29
FR2531433B1 (en) 1985-10-18
IL69450A (en) 1986-10-31
HU187600B (en) 1986-01-28
SE8304315D0 (en) 1983-08-08
PH20385A (en) 1986-12-08
ES8502992A1 (en) 1985-02-01
IT8322490A0 (en) 1983-08-09
DE3327705A1 (en) 1984-02-09
PT77168B (en) 1986-03-27
CH649998A5 (en) 1985-06-28
BE897473A (en) 1984-02-06
GB8321222D0 (en) 1983-09-07
MY8700166A (en) 1987-12-31
DK361983A (en) 1984-02-10
IL69450A0 (en) 1983-11-30
FR2531433A1 (en) 1984-02-10
ATA286383A (en) 1986-10-15
ES524815A0 (en) 1985-02-01
AU563736B2 (en) 1987-07-23
SE8304315L (en) 1984-02-10
FI73679C (en) 1987-11-09
FI73679B (en) 1987-07-31
GB2125041B (en) 1986-04-23
NZ205181A (en) 1986-07-11
DK361983D0 (en) 1983-08-08
FI832789A (en) 1984-02-10
GR78923B (en) 1984-10-02
NL8302776A (en) 1984-03-01
IT1168961B (en) 1987-05-20
PT77168A (en) 1983-09-01

Similar Documents

Publication Publication Date Title
AU575777B2 (en) Quinoline derivatives
AU1619488A (en) Carboxyalkenoic acid derivatives
AU2060283A (en) Alpha-aryl-1h-azolyl-1-ethanol derivatives
AU1425183A (en) I-piperazine derivatives
AU555417B2 (en) Benzodiazipine derivatives
AU563285B2 (en) Propynylaminoisoxazole derivatives
AU1800483A (en) Desoxyuridine derivatives
AU1565783A (en) Oxazoleacetic acid derivatives
AU558772B2 (en) Vinylthioacetamido oxacephalosporin derivatives
AU1631083A (en) Trans-delta2-prostoglandin d derivatives
AU563736B2 (en) Lysergic acid derivatives
AU572105B2 (en) N-substituted-phenothiazine derivatives
AU1962583A (en) Thiatriazine derivatives
AU1867883A (en) Sulfamoylbenzophenone derivatives
AU1382583A (en) Indolizidinylbenzamide derivatives
AU1719383A (en) Clavulanic acid derivatives
AU558459B2 (en) Apovincaminic acid derivatives
AU561694B2 (en) Pyridyloxybenzanilide derivatives
AU565078B2 (en) Acridanone derivatives
AU1092083A (en) Tetrahydro-2-pyrimidinone derivatives
AU1142083A (en) Lisergic acid derivatives
AU560306B2 (en) 3-azetidinylethyl-1-phenyl-2-imidazolidinone derivatives
AU554197B2 (en) Eburnane derivatives
AU2160083A (en) Pyrano-pyrazole derivatives
AU557503B2 (en) Naphthalenamine derivatives